Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II randomized open-label study of dacarbazine versus gemcitabine + dacarbazine in advanced adult soft tissue sarcomas
2005-001709-24Phase 2Active
- Sponsor
- Spanish Group for Research on Sarcoma
- Start
- Jun 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial in soft tissue sarcoma (STS) comparing Dacarbazine monotherapy with Gemcitabine + dacarbazine (2 arms). Primary endpoint: Progression-free rate at 3 months. Started Jun 2005; status: active.
02
Drugs
gemcitabinedacarbazine
03
Conditions
soft tissue sarcoma (STS)
Beyond the preview
Go deeper on 2005-001709-24.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-001709-24.